Outset Medical, Inc.
OM Nasdaq· Electromedical & Electrotherapeutic Apparatus
Last close · Oct 26, 2026
$4.08
KIRA · Stoqly’s AI analyst, in plain words
- Outset Medical, Inc. had $119M of revenue in fiscal 2025, up 5.1% on the year before. Over five years, revenue changed +19.1% a year on average.
- Its operating margin was −55.8%, up 43.9 pts: of every 100 in sales, about −56 is left after running the business.
- Outset Medical, Inc. lost $81.7M in fiscal 2025.
- Free cash flow was −$47.1M in fiscal 2025, −39.4% of revenue.
- Outset Medical, Inc. has $72.7M more cash than debt.
Market cap
$0.1M
P/E
—
Revenue
$119M
Net income
−$81.7M
Free cash flow
−$47.1M
Operating margin
−55.8%
Outset Medical, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+5.1%
Yes. Sales grew 5.1% last year.
Does it make a profit?
−68.3%
No. It lost money last year.
Does profit turn into cash?
−39.4%
No. It spent more cash than it brought in.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Outset Medical, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 13, 2026
- Legal name
- Outset Medical, Inc.
- CIK
- 0001484612
Outset Medical, Inc. · OM
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $103M | $115M | $130M | $114M | $119M |
| Revenue growth | 105.5% | 12.4% | 13.0% | −12.8% | 5.1% |
| Gross margin | 7.4% | 15.5% | 22.2% | 33.9% | 39.1% |
| Operating margin | −127.2% | −139.6% | −130.2% | −99.7% | −55.8% |
| Net income | −$132M | −$163M | −$173M | −$128M | −$81.7M |
| Net margin | −128.6% | −141.2% | −132.5% | −112.6% | −68.3% |
| Diluted EPS | −$2.89 | −$3.38 | −$52.28 | −$36.96 | −$5.37 |
| Cash | |||||
| Cash from operations | −$130M | −$146M | −$131M | −$116M | −$46.3M |
| Capital expenditure | $3.1M | $8.3M | $3.4M | $0.9M | $0.8M |
| Free cash flow | −$133M | −$154M | −$135M | −$117M | −$47.1M |
| FCF margin | −130.0% | −133.5% | −103.4% | −103.1% | −39.4% |
| Share count change | 178.0% | 5.7% | −93.2% | 6.1% | 334.3% |
| Debt and strength | |||||
| Cash and short-term investments | $339M | $288M | $203M | $159M | $169M |
| Debt incl. finance leases | $31.8M | $101M | $130M | $197M | $96.2M |
| Shareholders' equity | $374M | $246M | $123M | $26.8M | $127M |
| Current ratio | 7.9x | 7.2x | 5.3x | 5.7x | 6.7x |
| Interest coverage | −76.1x | −45.2x | −13.4x | −4.7x | −4.8x |
| Returns and quality | |||||
| Return on capital | −155.3% | −213.5% | −270.0% | −136.7% | −97.2% |
| Return on equity | −37.6% | −52.6% | −93.7% | −171.0% | −106.2% |
| Return on tangible equity | −35.3% | −66.2% | −140.6% | −477.2% | −64.3% |
| Piotroski F-score | 5 | 3 | 4 | 4 | 6 |
| Altman Z'' | 3.2 | −2.2 | −8.0 | −10.5 | −9.9 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$0.4M
5 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Outset Medical, Inc. · OM
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $4.08 a share, the company is worth $0.1M.
Source: SEC EDGAR XBRL filings (CIK 0001484612). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.